se of exhaled nitric oxide levels in predicting response to oral steroids in patients with COPD
Phase 3
Completed
- Conditions
- Chronic obstructive pulmonary disease (COPD)Respiratory - Chronic obstructive pulmonary disease
- Registration Number
- ACTRN12605000683639
- Lead Sponsor
- Health Research Council of New Zealand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with COPDFEV1 <70% predicted, FEV1/FVC ratio <70%Smoker or ex-smoker of at least 20 pack years.
Exclusion Criteria
Acute exacerbation within the last 3 months, patients receiving long-term oxygen treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method exercise capacity defined by 6 minute walk distance[Dec 08];exercise capacity defined by FEV1[Dec 08]
- Secondary Outcome Measures
Name Time Method St George Respiratory Questionnaire score.[Dec 08]